GA
LMAT icon

Geneva Advisors’s LeMaitre Vascular LMAT Stock Holding History

Geneva Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,115
Closed -$231K – 801
2016
Q4 		$231K Buy
+9,115
New +$202K ﹤0.01% 646

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geneva Advisors's LMAT Position: Q1 2017 in Review

Geneva Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2017, closing a stake of 9,115 shares — an estimated $231K sold.

Geneva Advisors first reported a position in LMAT in Q4 2016 and held it in 1 quarter. The position peaked at $231K in Q4 2016. 114 funds tracked by Wall St. Rank hold LMAT as of Q1 2017.

  • Geneva Advisors reported no remaining LeMaitre Vascular position as of Q1 2017 after selling out during the quarter.
  • Geneva Advisors sold 9,115 LeMaitre Vascular shares in Q1 2017, an estimated $231K.
  • Geneva Advisors first reported a position in LeMaitre Vascular in Q4 2016 and held it in 1 quarter.
  • Geneva Advisors's LeMaitre Vascular position peaked at $231K in Q4 2016.
  • 114 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2017.

Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.